Nasal spray could speed pain relief for sickle cell emergencies
NCT ID NCT04076748
First seen Jun 12, 2026 · Last updated Jun 12, 2026
Summary
This study tested a nasal spray painkiller (sufentanil) for adults having a sickle cell pain crisis. The goal was to see if it relieved severe pain faster than the standard gas treatment (EMONO), before both groups received morphine. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL CRISIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH de Cayenne
Cayenne, 97306, French Guiana
-
CHU Pointe à Pitre
Les Abymes, 97159, Guadeloupe
-
Gonesse Hospital
Gonesse, 95500, France
-
Hopital Pellegrin
Bordeaux, 33000, France
-
Hôpital Charles Nicolle
Rouen, 76031, France
-
Hôpital Edouard Herriot
Lyon, 69003, France
-
Hôpital Louis Mourier
Colombes, 92700, France
-
Hôpital Rangueil
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.